Novo Nordisk slashes Wegovy prices in India by up to 37% to boost sluggish sales of weight-loss drug
According to renowned endocrinologist Dr Shashank Joshi, a steep cut in the prices of Wegovy will help improve access and affordability. “But it has to be cautioned that weight loss drugs are not ...
Clinicians prescribing GLP-1 agents should ask about sexual function and consider medication review if new anorgasmia appears.
Philstar.com on MSN
13 more drugs VAT-exempt
Thirteen drugs for cancer and diabetes have been added to the list of essential medicines exempted from value-added tax or VAT, according to the Food and Drug Administration (FDA). Cancer drugs ...
The results were published in The New England Journal of Medicine as part of the OASIS 4 phase 3 trial. The findings show ...
This article was reviewed by Darragh O’Carroll, MD. Diabetes Medications for Weight Loss: What to Know Key takeaways: Some ...
Experimental pill versions of GLP-1 weight loss drugs by Novo Nordisk and Eli Lilly will receive FDA priority review. Read ...
Mediafeed on MSN
Thinking about GLP-1 for weight loss? Here’s the full scoop
This article was reviewed by Darragh O’Carroll, MD. GLP-1 for Weight Loss: Everything You Need to Know Key takeaways: GLP-1s ...
This article was reviewed by Darragh O’Carroll, MD. Oral vs. Injectable Semaglutide: Effectiveness & Side Effects Key ...
The SOUL trial, published in the New England Journal of Medicine, tracked 9,650 adults with type 2 diabetes and elevated cardiovascular risk over nearly four years.
The FDA has approved Rybelsus, the first oral GLP-1 receptor agonist, to reduce cardiovascular risk in type 2 diabetes ...
Despite success with injectable drugs pharma companies are investing heavily in tablets, long considered the holy grail of ...
The idea was beautifully simple. One pill taken daily to melt away those excess pounds. The new breed of GLP-1 oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results